期刊文献+

正常成人和非霍奇金淋巴瘤患者的骨髓间充质干细胞生物学特性的比较 被引量:2

Comparative study of non-Hodgkin lymphoma and normal adult bone marrow derived mesenchymal stem cells
原文传递
导出
摘要 目的比较研究非霍奇金淋巴瘤(NHL)患者和正常成人的骨髓间充质干细胞(MSCs)的生物学特性及分化能力,为临床细胞移植提供实验依据。方法获取并分离正常成人和NHL患者的骨髓MSCs,用低血清培养液培养、传代,观察MSCs的形态和生长特性,以流式细胞仪检测其免疫表型和细胞周期,体外诱导MSCs向脂肪和骨分化,行MSCs的染色体分析,电镜观察其超微结构。结果正常成人和NHL患者的骨髓MSCs具有相似的细胞形态、生长特性和免疫表型,而且都可以向骨和脂肪分化;NHL来源的MSCs具有正常的核型和超微结构,超过90%的细胞处于静止期,未发现肿瘤细胞的特征性结构。结论从NHL患者骨髓中获取的MSCs经培养传代,与正常成人骨髓MSCs一样,具有在体外大量扩增并保持低分化状态和多向分化的能力。 Objective To study the difference of biological characteristics between non-Hodgkin lymphoma (NHL) and normal adult bone marrow derived mesenchymal stem cells (MSCs), and examine their multiple differentiation capacity in order to provide experimental basis for cell based therapy. Methods MSCs were obtained from non-Hodgkin lymphoma and normal adult bone marrow and cultured in expanded medium. The growth curve, cell cycle and immunophenotype were investigated. Two different MSCs were induced into osteocyte and adipocyte, then, Von Kossa stain and Oilred O staining were used to identify the cells. The chromosome and ultrastructure of MSCs derived from NHL were detected too. Results Non-Hodgkin lympboma and normal adult derived MSCs were similar in cell morphology, growth pattern and immunophenotype. They showed a typical fibroblast like morphology. Under suitable conditions, MSCs could differentiate into adipocyte and osteoblast. Moreover, MSCs derived from NHL showed a normal chromosome and ultrastructure. At last, FACS revealed that more than 90% MSCs derived from NHL were at G0/G1 , and any structure characteristics of cancer cells were not found in NHL derived MSCs. Conclusion Similar to MSCs derived from normal adult bone marrow, MSCs derived from NHL bone marrow have the abilities of powerful proliferation in vitro and multiple differentiation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第9期527-530,共4页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献12

  • 1Jiang Y, Balkrishna N, Jahagirdar R, et al. Pluripotency of mesenchymal stem cell derived from adult marrow. Nature,2002, 418:41-49.
  • 2Reyes M, Lund T, Lenvik T, et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 2001, 98:2615-2625.
  • 3Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord bloodderived CD34 ( + ) cells in NOD/SCID mice. Exp Hematol,2002, 30 : 870-878.
  • 4Campagnoli C, Roberts IAG, Sailesh K, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood, 2001, 98:2396-2402.
  • 5Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains.Proc Natl Acad Sci USA, 1999, 96:10711-10716.
  • 6Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow,muscle, and brain. Exp Hematol, 2002, 30:896-904.
  • 7Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol, 1999, 181:67-73.
  • 8Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells,2003, 21 : 105-110.
  • 9Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002, 30:42-48.
  • 10Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med,1999, 5:309-313.

二级参考文献3

共引文献19

同被引文献16

  • 1施小凤,傅晋翔,李军,陈萍,袁育青,黄海雯,孙谕.间充质干细胞联合输注促进造血干细胞移植后的造血重建[J].中华器官移植杂志,2005,26(7):411-414. 被引量:12
  • 2陈宝安,李翠萍,周敏,高冲,丁家华.氨磷汀对化疗中造血干/祖细胞的保护作用[J].中国实验血液学杂志,2004,12(6):803-806. 被引量:3
  • 3赵智刚,唐晓琼,李静,史明霞,邹萍.慢性粒细胞性白血病骨髓间充质干细胞的分离纯化及其功能特性的研究[J].中华医学杂志,2005,85(29):2054-2057. 被引量:10
  • 4Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.Exp Hematol,2002,30(1):42-48.
  • 5Lazams HM,Koc ON,Devine SM,et al.Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.Biol Blood Marrow Transplant,2005,11 (5):389-398.
  • 6Le Blanc K,Rasmusson I,Sundberg B,et al.Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.Lancet,2004,363(9419):1439-1441.
  • 7Reyes M,Lund T,Lenvik T,et al.Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells.Blood,2001,98 (9):2615-2625.
  • 8Noort WA,Kruisselbrink AB,Anker PS,et al.Mesenchymal stem cells promote engraftment of human umbilical cord bloodderived CD34 (+) cells in NOD/SCID mice.Exp Hematol,2002,30 (8):870-878.
  • 9Krampera M,Glennie S,Dyson J,et al.Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.Blood,2003,101 (9):3722-3729.
  • 10Aggarwal S,Pittenger MF.Human mesenchymal stem cells modulate allogeneic immune cell responses.Blood,2005,105(4):1815-1822.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部